Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
glioblastoma
Biotech
Merck snaps up preclinical DNA biotech for $1.3B biobucks
The Big Pharma is spending $30 million to buy Modifi Biosciences while also putting $1.3 billion on the line if certain milestones are met.
Darren Incorvaia
Oct 23, 2024 7:05am
Kazia prunes failed cancer trial data set to form path to FDA
Jul 10, 2024 9:24am
mRNA vaccine for glioblastoma targets tumors in humans and dogs
May 7, 2024 5:30am
CAR-T for brain cancer extends survival in phase 1 trial
Mar 12, 2024 9:00am
'Quantum therapeutic' sparks glioblastoma cells to self-destruct
Sep 18, 2023 11:00am
ASCO: Servier finds survival benefit in difficult brain cancer
Jun 5, 2023 8:55am
